Autopsy report · NCT03623945
Autoantibodies in Breast Cancer Detection
Cause of deathFunding or business
“Study closed to enrollment and data and specimen collection due to lack of funding.”
Life of this trial
- Ran for about 5 years 8 months before it stopped.
- 1,279 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Sanford Health
- Sponsor type
- University, hospital or other
- Conditions
- Breast Cancer
- Interventions
- Collection of blood
- Participants
- 1,279
- Sites
- 2
- Countries
- United States
Trials that died the same way
- A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
“The study is closed due to lack of funding to support the study.” - Adipose Derived SVF for Aero-digestive & Enterocutaneous Fistulae
“Study closed due to lack of patient enrollment.” - Dim Light at Night in Patients With Obstructive Sleep Apnea
“The study was stopped due to lack of funding.” - Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer
“Study closed due to funding, 0 patient accrual.” - Use of Tranexamic Acid in Facial Fillers
“Study closed prior to opening to enrollment, due to funding availability for study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.